Send feedback

PCNT p.Ser2191Pro

c.6571T>C · rs34151633 · VCV159634

Benign/Likely benign Multiple submitters
Classification
Benign/Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 8 submitters
AlphaMissense
likely benign
0.0891 · ACMG-weighted
gnomAD v4.1
Common
common (popmax 8.28%, mid) — too common for a highly-penetrant pathogenic allele
Missense predictors
0/2 damaging
AlphaMissense, REVEL · SaProt no call
Conditions
1
microcephalic osteodysplastic primordial dwarfism type II

Computational evidence

Protein change
AlphaMissense0.0891likely benign
REVEL0.025moderately benign-leaning
SaProt—not scored · why
⇒ AlphaMissense and REVEL both call this tolerated; SaProt makes no call.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 0.015GERP -2.1
Regional constrainto/e 1.03unconstrained · MANE · 121 kb · p 0.027 · regional, not allelic
Overall
CADD11.56PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL is an independent agreement signal.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 8.28% Middle Eastern · 502/6,062 alleles
Filtering AF 7.68% ClinGen BA1/BS1 input FAF95, joint · FAF99 7.45%
Overall 4.05% 65,323/1,614,058 alleles · common exomes 60,161/1,461,724 · genomes 5,162/152,334 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 14.7% 7
Middle Easterngrpmax 8.28% 12
Amishnot grpmax-eligible 6.37% 16
Remaining individualsnot grpmax-eligible 4.53% 22
European (non-Finnish) 4.42% 23
Admixed American 3.25% 31
South Asian 1.84% 54
African / African-American 1.66% 60
Finnishnot grpmax-eligible 0.818% 122
East Asian 0.0111% 8,976

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
PCNT
Protein
p.Ser2191Pro
Coding
c.6571T>C
MANE Select
NM_006031
dbSNP
rs34151633
Type
single nucleotide variant
Location
chr21:46416489 (GRCh38)
Gene constraint
LOEUF 0.943 · pLI <0.01 (gnomAD)
Residue 2191
the 'disordered' region; a UniProt-annotated variant site (in)
Full PCNT gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/pcnt-p-ser2191pro (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown